Autopsy report · NCT04784182

Anti-anxiety Biotics for Breast Cancer Survivors

“Only three participants enrolled”

The sponsor’s own words in the registry.

Life of this trial

• Registered 5 months before it started.
• Ran for about 9 months before it stopped.
• 3 participants enrolled.
• Results were posted on the registry 1 year 4 months after it ended.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Auburn University

Sponsor type

University, hospital or other

Conditions

Anxiety Generalized; Breast Cancer Female

Interventions

probiotic plus prebiotic supplement; placebo

Participants

3

Sites

1

Countries

United States

Trials that died the same way

• Insulin Resistance Before and During Pregnancy in Women With Polycystic Ovary Syndrome
  “Only 2 participants were enrolled” (92% match in meaning)
• Long-term Benefit of Aortic Stent-graft in Patients With Distal Aortic Dissection
  “Not enough participants enrolled” (81% match in meaning)
• Validation of the Prostate Cancer Assay - Beta+Pivotal
  “No enrolled participants” (78% match in meaning)
• A Trial of Regorafenib Plus Lorigerlimab in Patients With Locally Recurrent or Regrowing pMMR/MSS Localized Rectal Cancer
  “0 participants enrolled” (78% match in meaning)
• Predictors and Prognostic Factors on the Acute Ischemic Stroke
  “Limited number of participants enrolled.” (77% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.